Mitchell E. Levinson serves as the Chief Strategy Officer at Pulse Biosciences Inc., a pioneering company in the field of bioelectric medicine. With a robust background in strategic planning and business development, Levinson has been instrumental in guiding Pulse Biosciences through its growth and innovation phases. Prior to joining Pulse Biosciences, he held various leadership positions in the healthcare and technology sectors, where he honed his skills in driving corporate strategy and fostering innovation. At Pulse Biosciences, Levinson is responsible for overseeing the company's strategic initiatives, which include the development and commercialization of its proprietary Nano-Pulse Stimulation (NPS) technology. This technology has shown promising results in non-thermal tissue treatment, particularly in the fields of dermatology and oncology. Under Levinson's strategic guidance, Pulse Biosciences has successfully expanded its research and development efforts, leading to significant advancements in clinical applications and market reach. Levinson's achievements at Pulse Biosciences are marked by his ability to navigate the complex landscape of medical technology and regulatory compliance. His leadership has been pivotal in securing key partnerships and investments, which have propelled the company's growth and solidified its position as a leader in bioelectric medicine. Levinson's strategic vision continues to drive Pulse Biosciences toward its mission of revolutionizing patient care through innovative, non-invasive treatments.